US 20120088746A1
· Shishido
· 2012
[cited by examiner]
CN 107176922A
· 2017
[cited by applicant]
Tian, et al., “Sulfation of melatonin: enzymatic characterization, differences of organs, species and genders, and bioactivity variation,”
[cited by applicant]
International Search Report and Written Opinion issued in International Patent Application No. PCT/US2019/065442, dated Mar. 17, 2020.
[cited by applicant]
International Preliminary Report on Patentability issued in International Patent Application No. PCT/US2019/065442, dated Jun. 25, 2021.
[cited by applicant]
Artimo, et al., “ExPASy: SIB bioinformatics resource portal,”
[cited by applicant]
Baker, et al., “Quantum chemistry in parallel with PQS,”
[cited by applicant]
Battiste, et al., “Utilization of site-directed spin labeling and high-resolution heteronuclear nuclear magnetic resonance for global fold determination of large proteins with limited nuclear overhauser effect data,”
[cited by applicant]
Berendsen, et al., “Gromacs—a Message-Passing Parallel Molecular-Dynamics Implementation,”
[cited by applicant]
Berton, et al., “New approaches to antidepressant drug discovery: beyond monoamines,”
[cited by applicant]
Blackwell B. “Monoamine oxidase inhibitor interactions with other drugs.”
[cited by applicant]
Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,”
[cited by applicant]
Brak, et al., “Identification of a New Class of Nonpeptidic Inhibitors of Cruzain,”
[cited by applicant]
Castañar, et al., “Chapter Four—Recent Advances in Small Molecule NMR: Improved HSQC and HSQMBC Experiments,”
[cited by applicant]
Chesney, et al., “Risks of all-cause and suicide mortality in mental disorders: a meta-review,”
[cited by applicant]
Cook, et al., “Testing the sulfotransferase molecular pore hypothesis,”
[cited by applicant]
Cook, et al., “The gate that governs sulfotransferase selectivity,”
[cited by applicant]
Cook, et al., “Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation,”
[cited by applicant]
Cook, et al., “A nucleotide-gated molecular pore selects sulfotransferase substrates,”
[cited by applicant]
Cook, et al., “High accuracy in silico sulfotransferase models,”
[cited by applicant]
Cook, et al., “The allosteric binding sites of sulfotransferase 1A1,”
[cited by applicant]
Cook, et al., “The structure of the catechin-binding site of human sulfotransferase 1A1,”
[cited by applicant]
Cook, “Controlling Sulfuryl-Transfer Biology,”
[cited by applicant]
Dajani, R., Hood, A. M., and Coughtrie, M. W. (1998) A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.
[cited by applicant]
Delaglio, et al., “NMRPipe: a multidimensional spectral processing system based on UNIX pipes,”
[cited by applicant]
Dormer, et al., “Highly Regioselective Friedländer Annulations with Unmodified Ketones Employing Novel Amine Catalysts: Syntheses of 2-Substituted Quinolines, 1,8-Naphthyridines, and Related Heterocycles,” J. Org. Chem.…
[cited by applicant]
Girvin, et al., “Determination of local protein structure by spin label difference 2D NMR: the region neighboring Asp61 of subunit c of the F1F0 ATP synthase,”
[cited by applicant]
Gochin, et al., “Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket,”
[cited by applicant]
Goldstein, “Sources and physiological significance of plasma dopamine sulfate.
[cited by applicant]
Heroux, et al., “Physical characterization of a monoamine-sulfating form of phenol sulfotransferase from human platelets,”
[cited by applicant]
Hildebrandt, et al., “Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies,”
[cited by applicant]
Kurogi et al., “Concerted actions of the catechol O-methyltransferase and the cytosolic sulfotransferase SULT1A3 in the metabolism of catecholic drugs,”
[cited by applicant]
Le Corre, et al., “Steady-state pharmacokinetics of dopamine in adult patients,”
[cited by applicant]
Lu, et al., “Crystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3′-phosphoadenosine 5′-phosphate,”
[cited by applicant]
Merikangas, et al., “Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication—Adolescent Supplement (NCS-A),”
[cited by applicant]
Meiser et al., “Compexity of dopamine metabolism”
[cited by applicant]
Nobili et al., “Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease”
[cited by applicant]
Olgiati, et al., “Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression,”
[cited by applicant]
Riches, et al., “Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT pie”,
[cited by applicant]
Salman, et al., “Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain,”
[cited by applicant]
Pronk, et al., “GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit,” Bioinformatics, vol. 29, No. 7, pp. 845-854 (2013).
[cited by applicant]
Schmitz, “Molecular dynamics with weighted time-averaged restraints for a DNA octamer. Dynamic interpretation of nuclear magnetic resonance data,”
[cited by applicant]
Liu, et. al. “AlzPlatform: An Alzheimer's Disease Domain-Specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research,”
[cited by applicant]
Solomon, “Relaxation Processes in a System of Two Spins,”
[cited by applicant]
Souery, et al., “Treatment resistant depression: methodological overview and operational criteria,”
[cited by applicant]
Sternbach H. “The serotonin syndrome.”
[cited by applicant]
Strott, “Sulfonation and molecular action,”
[cited by applicant]
Sun, et al., “The human estrogen sulfotransferase: a half-site reactive enzyme,”
[cited by applicant]
Suominen, “Determination of Serotonin and Dopamine Metabolites in Human Brain Microdialysis and Cerebrospinal Fluid Samples by UPLC-MS/MS: Discovery of Intact Glucuronide and Sulfate Conjugates,”
[cited by applicant]
Tang, et al., “Precise, facile initial rate measurements,”
[cited by applicant]
Thomas, et al., “Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression,”
[cited by applicant]
Van Der Spoel, et al., “GROMACS: fast, flexible, and free,”
[cited by applicant]
Wang, et al., “A Fast QM/MM (Quantum Mechanical/Molecular Mechanical) Approach to Calculate Nuclear Magnetic Resonance Chemical Shifts for Macromolecules,”
[cited by applicant]
Wang, et al., Development and testing of a general amber force field.
[cited by applicant]
Wang, et al., The Design and Interpretation of Human SULT1A1 Assays.
[cited by applicant]
Wang, et al., “3′-Phosphoadenosine 5′-phosphosulfate allosterically regulates sulfotransferase turnover,”
[cited by applicant]
Wang, et al., “Isozyme Specific Allosteric Regulation of Human Sulfotransferase 1A1,”
[cited by applicant]
Wang, et al., “The NSAID allosteric site of human cytosolic sulfotransferases,”
[cited by applicant]
Wang, et al., “Paradigms of sulfotransferase catalysis: the mechanism of SULT2A1,”
[cited by applicant]
Wang, et. al., “In Silico Prediction of Blood-Brain Barrier Permeability of Compounds by Machine Learning and Resampling Methods,”
[cited by applicant]
Whiteley, “Enzyme kinetics: partial and complete non-competitive inhibition,”
[cited by applicant]
Yamada, et al., “Clinical pharmacology of MAO inhibitors: safety and future,”
[cited by applicant]
Yamamoto, et al., “Determination of dopamine-3- and 4-O-sulphate in human plasma and urine by anion-exchange high-performance liquid chromatography with fluorimetric detection,”
[cited by applicant]
Zou, et al., “Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma,”
[cited by applicant]